Journal of the European Academy of Dermatology and Venereology · 2025 · 52 citations · 74 references
Life SciencesDermatologyImmunologyAllergyClinical ImmunologyHypersensitivityAllergic ConditionsAllergic DiseaseAllergy PharmacotherapyAtopic DermatitisDrug AllergyAtopic Dermatitis TreatmentAtopic PatientsImmunosuppressive CompoundsJak Inhibitor TherapyJanus Kinase Inhibitor TherapySystemic Drug TherapySystemic ImmunomodulatorsSystemic Therapy Selection
The evidence- and consensus-based living guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. The original EuroGuiDerm Guideline on atopic eczema was published in June 2022. Since then, the part of the guideline dealing with systemic therapy has been updated twice. This paper summarizes the results of the second update. Twenty-eight experts (including clinicians and patient representatives) from 12 European countries participated. The updated guideline provides guidance on which patients should be treated with systemic therapies, as well as recommendations and detailed information on each systemic drug. The systemic treatment options discussed in the guideline comprise conventional immunosuppressive drugs (azathioprine, ciclosporin, glucocorticosteroids, methotrexate and mycophenolate mofetil), biologics (dupilumab, lebrikizumab, nemolizumab and tralokinumab) and Janus kinase (JAK) inhibitors (abrocitinib, baricitinib and upadacitinib). Additionally, the updated guidelines address considerations for paediatric, adolescent, pregnant and breastfeeding patients. For all other aspects, please refer to the 2022 version.
74
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text
Medicine, Dermatology, Immunology +12
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.7K citations · Full text
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton et al. · New England Journal of Medicine · 2014 · 1.4K citations
Medicine, Dermatology, Immunology +13
Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text
Medicine, Dermatology, Immunology +17
Andreas Wollenberg, S. Barbarot, Thomas Bieber et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 1.2K citations · Full text
Medicine, Dermatology, Pediatrics +17